Loading…
Wilson's disease: A review of what we have learned
Wilson's disease (WD), which results from the defective ATP7B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatri...
Saved in:
Published in: | World journal of hepatology 2015-12, Vol.7 (29), p.2859-2870 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c459t-3ea0356d0c8145e5dabd4dc6ae0dbf2e0173f2d755277ad2d437ffd800e5ba033 |
---|---|
cites | cdi_FETCH-LOGICAL-c459t-3ea0356d0c8145e5dabd4dc6ae0dbf2e0173f2d755277ad2d437ffd800e5ba033 |
container_end_page | 2870 |
container_issue | 29 |
container_start_page | 2859 |
container_title | World journal of hepatology |
container_volume | 7 |
creator | Rodriguez-Castro, Kryssia Isabel Hevia-Urrutia, Francisco Javier Sturniolo, Giacomo Carlo |
description | Wilson's disease (WD), which results from the defective ATP7B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatric manifestations. A high grade of suspicion is warranted to not miss cases of WD, especially less florid cases with only mild elevation of transaminases, or isolated neuropsychiatric involvement. Screening in first and second relatives of index cases is mandatory, and treatment must commence upon establishment of diagnosis. Treatment strategies include chelators such as D-penicillamine and trientine, while zinc salts act as inductors of methallothioneins, which favor a negative copper balance and a reduction of free plasmatic copper. As an orphan disease, research is lacking in this field, especially regarding therapeutic strategies which are associated with better patient compliance and which could eventually also reverse established injury. |
doi_str_mv | 10.4254/wjh.v7.i29.2859 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4678372</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1751493191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-3ea0356d0c8145e5dabd4dc6ae0dbf2e0173f2d755277ad2d437ffd800e5ba033</originalsourceid><addsrcrecordid>eNpVkM9LwzAUx4MobsydvUluemmXpEmTeBDG8BcMvCgeQ9q82o6unU3X4n9vx-aY7_IevO_3-x4fhK4pCTkTfNav8rCTYcF0yJTQZ2hMNVeBoIqdn8wjNPV-RYbiPNZKXaIRi2PNqKBjxD6L0tfVrceu8GA93OM5bqAroMd1hvvctrgHnNsOcAm2qcBdoYvMlh6mhz5BH0-P74uXYPn2_LqYL4OUC90GEVgSidiRVFEuQDibOO7S2AJxScaAUBllzEkhmJTWMccjmWVOEQIiGazRBD3sczfbZA0uhaptbGk2TbG2zY-pbWH-b6oiN191Z3gsVSTZEHB3CGjq7y341qwLn0JZ2grqrTdUCsp1RDUdpLO9NG1q7xvIjmcoMTvYZoBtOmkG2GYHe3DcnH531P-hjX4BKc974A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751493191</pqid></control><display><type>article</type><title>Wilson's disease: A review of what we have learned</title><source>PubMed Central</source><creator>Rodriguez-Castro, Kryssia Isabel ; Hevia-Urrutia, Francisco Javier ; Sturniolo, Giacomo Carlo</creator><creatorcontrib>Rodriguez-Castro, Kryssia Isabel ; Hevia-Urrutia, Francisco Javier ; Sturniolo, Giacomo Carlo</creatorcontrib><description>Wilson's disease (WD), which results from the defective ATP7B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatric manifestations. A high grade of suspicion is warranted to not miss cases of WD, especially less florid cases with only mild elevation of transaminases, or isolated neuropsychiatric involvement. Screening in first and second relatives of index cases is mandatory, and treatment must commence upon establishment of diagnosis. Treatment strategies include chelators such as D-penicillamine and trientine, while zinc salts act as inductors of methallothioneins, which favor a negative copper balance and a reduction of free plasmatic copper. As an orphan disease, research is lacking in this field, especially regarding therapeutic strategies which are associated with better patient compliance and which could eventually also reverse established injury.</description><identifier>ISSN: 1948-5182</identifier><identifier>EISSN: 1948-5182</identifier><identifier>DOI: 10.4254/wjh.v7.i29.2859</identifier><identifier>PMID: 26692151</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><ispartof>World journal of hepatology, 2015-12, Vol.7 (29), p.2859-2870</ispartof><rights>The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-3ea0356d0c8145e5dabd4dc6ae0dbf2e0173f2d755277ad2d437ffd800e5ba033</citedby><cites>FETCH-LOGICAL-c459t-3ea0356d0c8145e5dabd4dc6ae0dbf2e0173f2d755277ad2d437ffd800e5ba033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678372/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678372/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26692151$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodriguez-Castro, Kryssia Isabel</creatorcontrib><creatorcontrib>Hevia-Urrutia, Francisco Javier</creatorcontrib><creatorcontrib>Sturniolo, Giacomo Carlo</creatorcontrib><title>Wilson's disease: A review of what we have learned</title><title>World journal of hepatology</title><addtitle>World J Hepatol</addtitle><description>Wilson's disease (WD), which results from the defective ATP7B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatric manifestations. A high grade of suspicion is warranted to not miss cases of WD, especially less florid cases with only mild elevation of transaminases, or isolated neuropsychiatric involvement. Screening in first and second relatives of index cases is mandatory, and treatment must commence upon establishment of diagnosis. Treatment strategies include chelators such as D-penicillamine and trientine, while zinc salts act as inductors of methallothioneins, which favor a negative copper balance and a reduction of free plasmatic copper. As an orphan disease, research is lacking in this field, especially regarding therapeutic strategies which are associated with better patient compliance and which could eventually also reverse established injury.</description><issn>1948-5182</issn><issn>1948-5182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkM9LwzAUx4MobsydvUluemmXpEmTeBDG8BcMvCgeQ9q82o6unU3X4n9vx-aY7_IevO_3-x4fhK4pCTkTfNav8rCTYcF0yJTQZ2hMNVeBoIqdn8wjNPV-RYbiPNZKXaIRi2PNqKBjxD6L0tfVrceu8GA93OM5bqAroMd1hvvctrgHnNsOcAm2qcBdoYvMlh6mhz5BH0-P74uXYPn2_LqYL4OUC90GEVgSidiRVFEuQDibOO7S2AJxScaAUBllzEkhmJTWMccjmWVOEQIiGazRBD3sczfbZA0uhaptbGk2TbG2zY-pbWH-b6oiN191Z3gsVSTZEHB3CGjq7y341qwLn0JZ2grqrTdUCsp1RDUdpLO9NG1q7xvIjmcoMTvYZoBtOmkG2GYHe3DcnH531P-hjX4BKc974A</recordid><startdate>20151218</startdate><enddate>20151218</enddate><creator>Rodriguez-Castro, Kryssia Isabel</creator><creator>Hevia-Urrutia, Francisco Javier</creator><creator>Sturniolo, Giacomo Carlo</creator><general>Baishideng Publishing Group Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151218</creationdate><title>Wilson's disease: A review of what we have learned</title><author>Rodriguez-Castro, Kryssia Isabel ; Hevia-Urrutia, Francisco Javier ; Sturniolo, Giacomo Carlo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-3ea0356d0c8145e5dabd4dc6ae0dbf2e0173f2d755277ad2d437ffd800e5ba033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez-Castro, Kryssia Isabel</creatorcontrib><creatorcontrib>Hevia-Urrutia, Francisco Javier</creatorcontrib><creatorcontrib>Sturniolo, Giacomo Carlo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez-Castro, Kryssia Isabel</au><au>Hevia-Urrutia, Francisco Javier</au><au>Sturniolo, Giacomo Carlo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Wilson's disease: A review of what we have learned</atitle><jtitle>World journal of hepatology</jtitle><addtitle>World J Hepatol</addtitle><date>2015-12-18</date><risdate>2015</risdate><volume>7</volume><issue>29</issue><spage>2859</spage><epage>2870</epage><pages>2859-2870</pages><issn>1948-5182</issn><eissn>1948-5182</eissn><abstract>Wilson's disease (WD), which results from the defective ATP7B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatric manifestations. A high grade of suspicion is warranted to not miss cases of WD, especially less florid cases with only mild elevation of transaminases, or isolated neuropsychiatric involvement. Screening in first and second relatives of index cases is mandatory, and treatment must commence upon establishment of diagnosis. Treatment strategies include chelators such as D-penicillamine and trientine, while zinc salts act as inductors of methallothioneins, which favor a negative copper balance and a reduction of free plasmatic copper. As an orphan disease, research is lacking in this field, especially regarding therapeutic strategies which are associated with better patient compliance and which could eventually also reverse established injury.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>26692151</pmid><doi>10.4254/wjh.v7.i29.2859</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1948-5182 |
ispartof | World journal of hepatology, 2015-12, Vol.7 (29), p.2859-2870 |
issn | 1948-5182 1948-5182 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4678372 |
source | PubMed Central |
title | Wilson's disease: A review of what we have learned |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T15%3A33%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Wilson's%20disease:%20A%20review%20of%20what%20we%20have%20learned&rft.jtitle=World%20journal%20of%20hepatology&rft.au=Rodriguez-Castro,%20Kryssia%20Isabel&rft.date=2015-12-18&rft.volume=7&rft.issue=29&rft.spage=2859&rft.epage=2870&rft.pages=2859-2870&rft.issn=1948-5182&rft.eissn=1948-5182&rft_id=info:doi/10.4254/wjh.v7.i29.2859&rft_dat=%3Cproquest_pubme%3E1751493191%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c459t-3ea0356d0c8145e5dabd4dc6ae0dbf2e0173f2d755277ad2d437ffd800e5ba033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1751493191&rft_id=info:pmid/26692151&rfr_iscdi=true |